Louisiana Governor signs a bill classifying two abortion-inducing drugs as controlled substances, sparking controversy among physicians and abortion rights advocates.
Key Points
Bill classifies mifepristone and misoprostol as controlled substances
Legislation aims to prevent coerced abortions
Physicians express concerns about potential negative impacts on reproductive health care
Pros
Protects expectant mothers from coerced abortions
Requires a prescription for abortion-inducing drugs
Cons
Could make it harder to prescribe medications for critical reproductive health care uses
May create barriers to physicians' ease of prescribing appropriate treatment